1. Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol 1997;48:191–214. PMID:
9046559.
2. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999–1010. PMID:
1353322.
3. Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G. Antioxidants as antidepressants: fact or fiction? CNS Drugs 2012;26:477–490. PMID:
22668245.
4. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008;358:55–68. PMID:
18172175.
5. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:676–692. PMID:
20471444.
6. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 2011;14:123–130. PMID:
20633320.
7. Raha S, Robinson BH. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 2001;106:62–70. PMID:
11579426.
8. Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. Cell culture models of oxidative stress and injury in the central nervous system. Curr Neurovasc Res 2005;2:73–89. PMID:
16181101.
9. Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 2008;29:346–351. PMID:
18538422.
10. Filomeni G, Ciriolo MR. Redox control of apoptosis: an update. Antioxid Redox Signal 2006;8:2187–2192. PMID:
17034362.
11. Halliwell B. Phagocyte-derived reactive species: salvation or suicide? Trends Biochem Sci 2006;31:509–515. PMID:
16890439.
12. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 2006;141:312–322. PMID:
16760481.
13. Lee SY, Lee SJ, Han C, Patkar AA, Masand PS, Pae CU. Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2013;46:224–235. PMID:
23022673.
14. Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1284–1290. PMID:
21515329.
15. Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R. Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 2009;63:639–645. PMID:
19674383.
16. Galecki P, Szemraj J, Bienkiewicz M, Florkowski A, Galecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep 2009;61:436–447. PMID:
19605942.
17. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001;64:43–51. PMID:
11292519.
18. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007;22:67–73. PMID:
17299810.
19. Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004;286:R431–R444. PMID:
14761864.
20. Sofic E, Rustembegovic A, Kroyer G, Cao G. Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm 2002;109:711–719. PMID:
12111462.
21. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277–285. PMID:
15003729.
22. Brainina Kh Z, Ivanova AV, Sharafutdinova EN, Lozovskaya EL, Shkarina EI. Potentiometry as a method of antioxidant activity investigation. Talanta 2007;71:13–18. PMID:
19071260.
23. Lee GJ, Lee SK, Kim JM, Rhee CK, Lee YK, Brainina KZ, et al. Application feasibility of antioxidant activity evaluation using potentiometry in major depressive disorder. Electrochemistry 2014;82:264–266.
24. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–296. PMID:
6080235.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571. PMID:
13688369.
26. Zhou X, Min S, Sun J, Kim SJ, Ahn JS, Peng Y, et al. Extending a structural model of somatization to South Koreans: cultural values, somatization tendency, and the presentation of depressive symptoms. J Affect Disord 2015;176:151–154. PMID:
25721611.